|
ARTL Artelo Biosciences Inc 1621221 |
| Income Statement |
|
Net Income
|
artl_10k
|
-9,826,000 |
| Balance Sheet |
|
Current Assets
|
2,557,000 |
|
Assets
|
4,698,000 |
|
Current Liabilities
|
1,772,000 |
|
Liabilities
|
1,841,000 |
|
Equity
|
2,857,000 |
|
Shares Out
|
3,228,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-8,350,000 |
|
Investing Cash Flow
|
7,769,000 |
| Market Analysis |
Market Cap
|
3,750,590 |
|
Price
|
0.98 |
|
BVPS
|
0.89 |
|
PB
|
1.06 |
|
EPS
|
-3.33 |
|
PS
|
0.25 |
|
FCF
|
-581,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARTL documents filed with the SEC.
ARTL Filings
Clear
